Simplify Propel Opportunities ETF is a ETF series of Simplify Exchange Traded Funds (series S000078061). Net assets $69.4M as of 2026-03-31.
Showing 15 of 48 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| United States Treasury Bills | — | $64.5M | 9293.41% |
| Plains GP Holdings LP | — | $30.9M | 4454.62% |
| Achieve Life Science Inc | — | $3.5M | 502.16% |
| Phathom Pharmaceuticals Inc | — | $2.9M | 420.35% |
| Delcath Systems Inc. | — | $2.4M | 349.42% |
| Abeona Therapeutics Inc. | — | $2.2M | 323.22% |
| Celldex Therapeutics Inc. | — | $2.2M | 315.57% |
| Milestone Pharmaceuticals Inc | — | $1.8M | 258.49% |
| Oculis Holding AG | — | $1.8M | 255.61% |
| LeonaBio Inc. | — | $1.5M | 221.28% |
| Corcept Therapeutics Inc. | — | $1.5M | 219.50% |
| Kyverna Therapeutics Inc | — | $1.5M | 215.41% |
| Inventiva SA | — | $1.3M | 182.40% |
| Viridian Therapeutics Inc | — | $1.1M | 158.60% |
| Aquestive Therapeutics Inc | — | $972K | 140.20% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $69.4M |
| 2025-12-31 | $75.2M |
| 2025-09-30 | $69.1M |
| 2025-06-30 | $65.0M |
| 2025-03-31 | $68.8M |
| 2024-12-31 | $71.4M |
| 2024-09-30 | $104.2M |
| 2024-06-28 | $96.9M |